Body mass index above 24 is beneficial for the 6-month survival rate in hepatocellular carcinoma patients with extrahepatic metastases

Asia Pac J Clin Nutr. 2017;26(4):637-641. doi: 10.6133/apjcn.062016.03.

Abstract

Background and objectives: To investigate the effect of overweight status on the 6-month survival rate in patients with extrahepatic hepatocellular carcinoma (HCC).

Methods and study design: We retrospectively analyzed the records of 51 patients with hepatocellular carcinoma and extrahepatic metastases between 2007 and 2010 before treatment. The associations among overweight status (body mass index [BMI] >24 kg/m2), demographic variables, and survival outcome were analyzed by univariate and multivariate analysis.

Results: BMI>24 kg/m2 was significantly associated with the 6-month survival rate (p=0.042). Gender (p=0.149), Child Pugh classification (p=0.149), Okuda staging (p=0.093), and albumin concentration >3.5 mg/dL (p=0.082) showed marginal survival benefits in univariate analysis. Multivariate analysis confirmed that BMI >24 kg/m2 was an independent prognostic factor for the 6-month survival rate (p=0.03).

Conclusions: BMI >24 kg/m2 was associated with an improved 6-month survival rate in patients with extrahepatic metastatic hepatocellular carcinoma.

MeSH terms

  • Adrenal Gland Neoplasms / secondary
  • Aged
  • Aged, 80 and over
  • Body Mass Index*
  • Bone Marrow Neoplasms / secondary
  • Bone Neoplasms / secondary
  • Brain Neoplasms / secondary
  • Carcinoma, Hepatocellular / pathology*
  • Female
  • Humans
  • Liver Neoplasms / pathology*
  • Lung Neoplasms / secondary
  • Lymph Nodes / pathology
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / secondary